Corrigendum to: CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz

Clin Infect Dis. 2022 Mar 1;74(4):755. doi: 10.1093/cid/ciab804.

Authors

Rulan Griesel^{1

2}, Gary Maartens^{1

2}, Maxwell Chirehwa¹, Simiso Sokhela³, Godspower Akpomiemie³, Michelle Moorhouse³, Francois Venter³, Phumla Sinxadi^{1

2}

Affiliations

¹ Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
² Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
³ Ezintsha, Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

No abstract available

Publication types

Published Erratum